Skip to main content
FinSpry Logo
FinSpry
MRNA logo
MRNA
(NASDAQ)
Moderna, Inc.
$49.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Moderna (MRNA) Stock Price & Financial Analysis

Moderna Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$48.11 - $50.51
52-Week High$59.55
52-Week Low$22.28
Open$48.15
Volume4.60M
Average Volume (3M)4.60M
Market Cap19.14B
Shares Outstanding389.00M
Price to Sales (P/S)10.12
Price to Book (P/B)2.25
EV/EBITDA-7.36
Revenue (TTM)1.92B
Net Income (TTM)-2.82B
Free Cash Flow (TTM)-2.05B
EPS (TTM)$-7.20
Profit Margin-146.67%
Operating Margin-159.77%
Return on Equity (ROE)-32.62%
Debt to Equity0.22
50-Day MA$49.10
200-Day MA$33.42
52-Week Change84.20%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Moderna

What is the current stock price for MRNA?

As of the latest trading session, MRNA stock trades at $49.20. The 52-week range is $22.28–$59.55, with a day range of $48.11–$50.51.

What is the P/E ratio for MRNA?

The P/E ratio (Price-to-Earnings) for MRNA is shown in the Key Statistics section. This valuation metric helps compare Moderna, Inc. to industry peers.

Does MRNA pay dividends?

Moderna does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MRNA?

Based on 6 analysts, the consensus for MRNA is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MRNA?

Moderna's market capitalization is $19.14B, classifying it as a large-cap company. Moderna operates in the Healthcare sector within the Biotechnology industry.